Arnaud Charil

Arnaud Charil is a seasoned professional in the field of clinical pharmacology and translational medicine, currently serving as Senior Director and Head of Translational Imaging at Eisai US. With prior roles as Director of Clinical Imaging at Novartis and Principal Research Scientist in Clinical Imaging at Eli Lilly and Company, Arnaud brings extensive expertise in imaging methodologies. Additionally, experience as an Honorary Research Fellow and Research Affiliate at the University of Sydney further underscores a strong academic background. Arnaud Charil holds a PhD in Neurological Sciences from McGill University and completed a Post-Doctoral Fellowship in Neuroscience/Neuroimaging at the same institution.